Taiwan Advance Bio-Pharmaceutical Inc. (TPEX:4186)
Taiwan · Delayed Price · Currency is TWD 10.20
-0.05 (-0.49%)
May 29, 2026, 1:13 PM CST
TPEX:4186 Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 28.05 | 22.88 | -10.68 | 3.17 | -118.53 |
Depreciation & Amortization | 19.69 | 20.62 | 25.9 | 28.18 | 30.39 |
Loss (Gain) From Sale of Assets | - | 0.03 | -0.38 | -0.01 | 0.03 |
Asset Writedown & Restructuring Costs | - | - | 9.15 | 1.89 | 6.05 |
Loss (Gain) From Sale of Investments | -2.43 | 14.69 | 1.23 | -2.58 | -2.06 |
Provision & Write-off of Bad Debts | 8.41 | 3.58 | 1.84 | 0.79 | 0.1 |
Other Operating Activities | -2.33 | -1.15 | -0.99 | 0.23 | 5.78 |
Change in Accounts Receivable | -6.65 | -50.13 | 10.01 | 4.99 | -13.6 |
Change in Inventory | -1.42 | 3.06 | 2.48 | 0.21 | -0.41 |
Change in Accounts Payable | 5.05 | -1.26 | 0.3 | -0.81 | -2.32 |
Change in Unearned Revenue | 2.38 | 9.55 | 0.72 | -35.48 | 37.69 |
Change in Other Net Operating Assets | 2.38 | -13.54 | -26.96 | -21.18 | 8.8 |
Operating Cash Flow | 53.13 | 8.33 | 12.61 | -20.59 | -48.08 |
Operating Cash Flow Growth | 538.04% | -33.95% | - | - | - |
Capital Expenditures | -33.36 | -3.96 | -11.94 | -7.28 | -15.19 |
Sale of Property, Plant & Equipment | - | 0.26 | 1.4 | 1.16 | - |
Sale (Purchase) of Real Estate | -3.66 | - | - | - | - |
Investment in Securities | -9.66 | 0.29 | -1.8 | -3.01 | - |
Other Investing Activities | -1.58 | 1.19 | -1.36 | 0.3 | -0 |
Investing Cash Flow | -48.25 | -2.22 | -13.7 | -8.83 | -15.2 |
Short-Term Debt Issued | 40 | - | 49.06 | 23.09 | - |
Long-Term Debt Issued | - | - | 16 | 40 | 30.7 |
Total Debt Issued | 40 | - | 65.06 | 63.09 | 30.7 |
Short-Term Debt Repaid | - | -40 | - | - | -9.05 |
Long-Term Debt Repaid | -10.47 | -41.92 | -40.38 | -34.69 | -35.62 |
Total Debt Repaid | -10.47 | -81.92 | -40.38 | -34.69 | -44.67 |
Net Debt Issued (Repaid) | 29.53 | -81.92 | 24.67 | 28.39 | -13.97 |
Other Financing Activities | - | - | - | -0.11 | 0.05 |
Financing Cash Flow | 29.53 | -81.92 | 24.67 | 28.28 | -13.92 |
Net Cash Flow | 34.41 | -75.81 | 23.58 | -1.14 | -77.2 |
Free Cash Flow | 19.77 | 4.37 | 0.67 | -27.87 | -63.28 |
Free Cash Flow Growth | 352.74% | 554.72% | - | - | - |
Free Cash Flow Margin | 5.42% | 1.23% | 0.21% | -8.76% | -26.00% |
Free Cash Flow Per Share | 0.22 | 0.05 | 0.01 | -0.31 | -0.70 |
Cash Interest Paid | - | 7.41 | 7.27 | 6.13 | 7.43 |
Cash Income Tax Paid | - | - | -0.01 | - | 0 |
Levered Free Cash Flow | 0.3 | -33.65 | 60.04 | -11.92 | -15.82 |
Unlevered Free Cash Flow | 4.37 | -29.01 | 64.6 | -8.09 | -11.17 |
Change in Working Capital | 1.74 | -52.32 | -13.45 | -52.27 | 30.15 |